Overview

This trial is active, not recruiting.

Condition

prostate cancer

Sponsor

Source MDx

Start date

December 2009

Trial size

1200 participants

Trial identifier

NCT00966095, PReCISE

Summary

The purpose of this study is to develop and validate a blood-based diagnostic test that
will predict prostate biopsy outcome as positive or negative for prostate cancer. Such a
test will serve to reduce the number of unnecessary prostate biopsies.